SCHEMBL21099812

SCHEMBL21099812

CC(C)Sc1ccccc1Nc1nc(Nc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2)nc2ccsc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCND3 P30281 2/20 0.54
▸ CCNK O75909 1/20 0.54
▸ CCNA2 P20248 1/20 0.54
▸ CDK2 P24941 1/20 0.54
▸ CDK9 P50750 1/20 0.54
▸ CDK6 Q00534 1/20 0.54
▸ JAK2 O60674 4/20 0.48
▸ JAK3 P52333 3/20 0.48
▸ EGFR P00533 6/20 0.48
▸ IRAK4 Q9NWZ3 2/20 0.47
▸ BRD4 O60885 1/20 0.47
▸ ABCB11 O95342 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ HTR1A P08908 1/20 0.44
▸ ADRA2A P08913 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ DRD1 P21728 1/20 0.44
▸ TBXA2R P21731 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21100262 0.87 ALK (0.57) CCND3CCNKCCNA2CDK2CDK9
SCHEMBL21099556 0.87 IRAK4 (0.56) CCND3CCNKCCNA2CDK2CDK9
SCHEMBL21100193 0.83 IRAK4 (0.59) JAK2EGFRIRAK4BRD4ALK
SCHEMBL21099819 0.74 IRAK4 (0.53) JAK2JAK3EGFRIRAK4BRD4
SCHEMBL21099679 0.74 CCND3 (0.51) CCND3CCNKCCNA2CDK2CDK9
SCHEMBL19867185 0.74 ALK (0.63) CDK2JAK2JAK3EGFRIRAK4
SCHEMBL21099501 0.74 ALK (0.52) EGFRPTK2ALK
SCHEMBL21099549 0.74 IRAK4 (0.41) CCND3CCNKCCNA2CDK2CDK9
SCHEMBL19867214 0.73 PTK2 (0.59) JAK2EGFRIRAK4BRD4ABCB11
SCHEMBL22807484 0.72 SRC (0.70) EGFRABCB11ESR1CHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3498716-A1 THIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATIONS Hongyun Biotech Co., Ltd. (CN) 2019-06-19 — — EP disclosed
Send feedback